Navigation Links
Call for Applications: The Amgen Award for Science Teaching Excellence
Date:11/4/2009

THOUSAND OAKS, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that it now invites applications for its 19th annual Amgen Award for Science Teaching Excellence (AASTE). This award is designed to recognize and honor extraordinary science teachers at the K-12 level who significantly impact their students through exemplary science teaching and who achieve demonstrated results in student learning in communities where Amgen operates.

With a longstanding commitment to science education, Amgen established the teacher awards program to promote and encourage science excellence in public and private schools. Since the program's inception in 1992, Amgen has awarded nearly $2.5 million to educators who have made exceptional science-teaching contributions and who have significantly impacted the lives of their students.

Amgen will honor a total of 34 teachers in states where Amgen has operating sites: California, Colorado, Kentucky, Massachusetts, Puerto Rico, Rhode Island, Washington and Canada (Alberta, British Columbia, Ontario and Quebec).

"Outstanding teachers motivate, inspire and prepare students for a better understanding of science and how it applies to the world around them," said Phyllis Piano, vice president, Corporate Communications and Philanthropy at Amgen. "Amgen is proud to honor educators in our communities who are dedicated to science teaching excellence and we look forward to recognizing their accomplishments."

The 34 selected winners within the United States, Puerto Rico and Canada will receive the following benefits:

  • An unrestricted cash award of $5,000 USD or $5,000 CAD; and
  • A restricted $5,000 USD or $5,000 CAD cash grant to the recipient's school for the expansion or enhancement of a school science program, science resources, or the
    '/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
10. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
11. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ACH, Calif., Dec. 1 Reproductive P...ve Single Embryo Transfer (eSET) Encouragement Pro... with good embryo quality and a good prognosis for...by transferring a single embryo. ,, The biggest...s reducing the number of multiple pregnancies, eve...
(Date:12/1/2009)...W YORK, Dec. 1 Reportlinker.com an...able in its catalogue: ,, HPLC Systems & A...www.reportlinker.com/p0164366/HPLC-Systems--Access... years, Liquid Chromatography has emerged as a wor...s, food and beverage, research and development, an...
(Date:12/1/2009)...LLEVUE, Wash., Dec. 1 dr...ne retailer of health, beauty, vision, and pharmac...its best day ever as customer orders were the high...rugstore.com and Beauty.com web stores featured...eir largest gift selection yet. ,, (Logo: http...
Breaking Medicine Technology:Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 54127 1Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 54127 2Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 54127 3Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 54127 4Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 54127 5Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement 54127 6PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 1PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 2PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 3PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 4PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 5PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 6PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 7PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 8PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 9PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 10PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 11PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 12PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 13PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 14PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 15PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 16PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 17Podcast Alert 3A Measures For Asthma Success 54120 1
...ined virologic response in non-responders ...lts in line with previous studies of long-acting i...ess frequent dosing -, - Final data from Phase 2 ...nual Meeting of the American Association for the S... (AASLD) -, ROCKVILLE, Ma., Nov. 5 Human Genom...
...sdaq: IOMI ) today announced that Stanley C. Erck...cer, will present at the Acumen BioFin,Rodman & Re... City on,Monday, Nov. 5. Mr. Erck,s presentation w... I Room of the New York Palace Hotel. Mr. Erck,s ...tch-based,needle-free vaccines and immunostimulant...
Other Medicine Technology:Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 2Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 5Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 6Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5 2
(Date:12/1/2009)...easingly common but more easily identified, study ...s) -- A magnetic resonance imaging test is highly...cy complication called placenta accreta, researche...enta surrounding a fetus attaches too deeply to a ...pull out parts of the uterine wall, rupturing bloo...
(Date:12/1/2009)... CAEAR Foundation Changes Name to HealthHIV , ...e CAEAR Foundation, one of the largest national HI...o HealthHIV and launching a new website. The annou... of a campaign to promote the organization’s... , , , ,“HealthHIV clearly, quickly and eas...
(Date:12/1/2009)...NS, Dec. 1 The American...professional association of blood specialists, exp...nual Meeting from December 5-8, 2009, at the Ernes...The meeting will showcase the latest research and ...leasure to host ASH,s 51st annual meeting, where w...
(Date:12/1/2009)...TON, Dec. 1 On December...,538 federal prisoners were HIV positive or had co...S) in the Office of Justice Programs, U.S. Departm...an estimated 5,672 inmates in state and federal pr... In 2007, about 43 per 10,000 prison inmates were ...
(Date:12/1/2009)...evelopment of simple screening test, expert says ,...n a finding that could lead to a simple blood test...identified immune system markers that indicate ear...ng cancer. , The researchers examined gene expr...with non-small cell lung cancer and a control grou...
Breaking Medicine News(10 mins):Health News:Serious Pregnancy Complication Detected With MRI 2Health News:National HIV Non-Profit Announces New Name 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:Gene 'Signature' May Point to Lung Cancer 2
...benefits, but surgeons rethinking,one-size-fits-al...ients,who undergo foot and ankle surgery are recov...ks to new minimal incision techniques and tools. A...sions for the,sake of small incisions," says Lawre...
... LifeMasters Supported SelfCare,Inc., a national ... that it,has received an extension from the Center...sease management demonstration project in Florida....e,fee for service beneficiaries (Medicare/Medicaid...
...over the American Stroke Associations Internationa...08 at the Ernest N. Morial Convention Center in Ne...in the world of medical scientists and physicians ...ond year, the American Association of Neurological...
...Feb. 19 The Ensign,Group, Inc. (Nasdaq: ENSG ), ...led nursing, rehabilitative care services and assi...Park skilled nursing facility in,Tucson, Arizona h...p://www.newscom.com/cgi-bin/prnh/20071213/LATH168L...
...ary 19, 2008 New findings show that a specialized...ling genes can selectively target tumors in the br...sue remained virtually untouched, according to a F..., Most importantly, this study finds that the vir...
...rly Kent, the daughter of,Virginia Kent, Deceased,...urt for her mother,s death, which was caused by th...g Company immunity law is being challenged., All ...smissed and all Michigan victims were denied compe...
Other Medicine News:Health News:Surgeons Rethink Approach to Minimal Incision Foot and Ankle Surgery 2Health News:The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida 2Health News:The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida 3Health News:The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program 2Health News:The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program 3Health News:Tumor-killing virus selectively targets diseased brain cells 2Health News:Michigan Resident, Kimberly Kent's Drug Product Liability Case Will Be Argued in the United States Supreme Court on February 25, 2008 2
H-III Auto-Photomicrographic Film Camera
Hema-G Wright-Giemsa Stain
...nol for faster, more complete staining of blood, c...acturing process yields a stain that rapidly penet...tion of cytoplasmic structure, distinct nuclear de...ear. Used as a differential stain for: blood morph...
Hema-Quik II
Medicine Products: